ARS Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 26 12:11 ET
ARS Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 26 11:51 ET
ARS Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Sep 1, 2023 13:46 ET
ARS Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Aug 1, 2023 17:16 ET
ARS Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jul 3, 2023 14:12 ET
ARS Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jun 1, 2023 17:07 ET
ARS Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
May 8, 2023 16:34 ET
ARS Pharmaceuticals | EFFECT: Others
May 4, 2023 00:15 ET
Silverback Therapeutics | EFFECT: Others
Jan 14, 2022 00:15 ET
Silverback Therapeutics | 424B4: Prospectus
Dec 4, 2020 16:04 ET
Silverback Therapeutics | EFFECT: Others
Dec 4, 2020 00:15 ET
Silverback Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange
Dec 1, 2020 16:31 ET
No Data
No Data